A new study finds that regulatory gene variants can affect the severity of a genetic disease among people with the same protein-coding mutation.
Andrea Califano and his investigative team discover a molecular signaling mechanism underlying a specific type of highly aggressive breast cancer.
Kyle Allison, recipient of the NIH Director’s Early Independence Award, is exploring how to keep common bacterial infections from becoming chronic illnesses.
Using an innovative algorithm, CUMC researchers have found that loss of a gene called KLHL9 is the driving force behind the most aggressive form of glioblastoma, the most common form of brain cancer.
New technology allows scientists to dive into the inner world of cells in everything from cancers to mummies. Learn more at lab’s open house on July 10.
P&S systems biologists dive into huge databases of genomes, proteins, and metabolites to find new ways to target the world’s most deadly pathogens.